Sodium voltage-gated channel alpha subunit (Na_v_ alpha subunit)

The **Sodium voltage-gated channel alpha subunits** are large transmembrane proteins that form the core pore of voltage-gated sodium channels responsible for the rapid upstroke phase of action potentials in excitable cells such as neurons and muscle fibers[1][2]. Each functional sodium channel consists primarily of a single large α-subunit (~2000 amino acids) organized into four homologous domains (I–IV), each containing six membrane-spanning segments. The S4 segment acts as a voltage sensor; upon depolarization, it triggers conformational changes that open the central pore allowing selective influx of Na^+ ions[1][5]. This process is essential for electrical excitability and signal transmission. There are nine main human genes encoding distinct α-subunits—SCN1A through SCN11A—each giving rise to different isoforms with tissue-specific expression patterns and physiological roles[4]. These channels are modulated by accessory β-subunits which influence their kinetics and localization but do not form the ion-conducting pore themselves. Voltage-gated sodium channels are major therapeutic targets in neurology, cardiology, anesthesiology, and pain medicine. Drugs targeting these channels act mainly by blocking ion flow through the α-subunit or altering its gating properties. Mutations in genes encoding these proteins underlie several inherited disorders including epilepsy syndromes, cardiac conduction diseases like Brugada syndrome or long QT syndrome type 3, some forms of chronic pain including erythromelalgia due to gain-of-function mutations in SCN9A/Na_v_1.7[3]. These targets present significant safety challenges because their widespread distribution means off-target effects can impact vital functions like heartbeat regulation or neuronal excitability[2][4]. *Note*: Specific drugs may target specific isoforms such as Na_v_1.7 or Na_v_1.5[2][4].

Other names

Voltage-gated sodium channel alpha subunitVGSC alpha subunitNa_v_ alphaSCN family (e.g., SCN1A for type 1)Sodium channel protein type X subunit alpha (where X = 1–11)

Blockade of sodium influx through the pore-forming alpha subunit to inhibit action potential generation or propagation[2][4]. Modulation of gating properties to alter activation/inactivation kinetics.